HTLV-I infection is cripplingBMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6923.273b (Published 22 January 1994) Cite this as: BMJ 1994;308:273
- J A Copplestone,
- A G Prentice,
- M D Hamon,
- J Gawler,
- N Anderson
- Department of Haematology, Derriford Hospital, Plymouth PL6 8AP
- Department of Neurology, St Bartholomew's Hospital, London EC1A 7BE
- Blood Services South West, Southmead Hospital, Bristol BS10 5ND.
EDITOR, - M Brennan and colleagues1 and A G Dalgleish2 conclude that the low prevalence of infection with human T cell leukaemia/lymphoma virus type I (HTLV-I) in Britain means that screening blood donors for antibodies to this virus is not cost effective. Though we accept the economic arguments, the consequences of such a policy can be tragic for …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial